CVnCoV
- Turkiye
GSK and CureVac to develop next-generation mRNA Covid-19 vaccines
GSK will also support the production of up to 100 million doses of CureVac’s Covid-19 vaccine candidate CVnCoV this year.…
Read More »
GSK will also support the production of up to 100 million doses of CureVac’s Covid-19 vaccine candidate CVnCoV this year.…
Read More »